Overview

Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD)

Status:
No longer available

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This protocol allows for the treatment of patients, male and female, between the ages of 18 years and 70 years. Patients must have failed to respond to steroid treatment for Grade C-D acute GVHD.

Details

Lead Sponsor:

Mesoblast International Sàrl
Mesoblast, Inc.

Treatments:

Remestemcel-l